#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15738	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2138	731.5	0	.	n	.	0	C451T	SNP	451	451	C	766	766	T	863	T,C	613,216	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15738	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2138	731.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1499	1499	C	895	C	846	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15738	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2138	731.5	0	HET	.	.	.	C207T	.	207	207	C	522	522	C	845	C,T	601,197	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28378	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3498	808.0	0	.	n	.	0	T695C	SNP	695	695	T	1050	1050	C	862	C	816	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28378	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3498	808.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2326	2326	C	906	C	846	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28378	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3498	808.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2400	2400	A	897	A,G	845,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28378	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3498	808.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2952	2952	C	860	C	811	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28378	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3498	808.0	0	HET	.	.	.	A1638G	.	1638	1638	A	1993	1993	A	918	A,G	677,180	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2288	folP	855	855	100.0	folP.l15.c4.ctg.1	1460	155.4	1	SNP	p	R229S	1	.	.	685	687	AGC	991	993	AGC	218;220;221	A;G;C	205;207;206	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6108	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3525	172.8	1	SNP	p	S91F	1	.	.	271	273	TTC	581	583	TTC	221;220;218	T;T;C	208;207;207	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6108	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3525	172.8	1	SNP	p	D95G	1	.	.	283	285	GGC	593	595	GGC	211;211;211	G;G;C,T,A	198;197;195,1,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6108	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3525	172.8	1	SNP	p	G95N	0	.	.	283	285	GGC	593	595	GGC	211;211;211	G;G;C,T,A	198;197;195,1,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1856	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1412	130.8	1	SNP	p	G45D	0	.	.	133	135	GGC	588	590	GGC	219;222;224	G;G;C	205;210;212	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	960	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1048	91.1	0	.	n	.	0	A197.	DEL	197	197	A	550	550	A	202	A	197	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5438	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3134	172.9	1	SNP	p	D86N	0	.	.	256	258	GAC	644	646	GAC	191;192;194	G;A;C	180;178;184	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5438	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3134	172.9	1	SNP	p	R87W	0	.	.	259	261	CGT	647	649	CGT	191;190;190	C,A;G;T	181,1;182;180	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5438	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3134	172.9	1	SNP	p	S87R	1	.	.	259	261	CGT	647	649	CGT	191;190;190	C,A;G;T	181,1;182;180	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5438	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3134	172.9	1	SNP	p	R87I	0	.	.	259	261	CGT	647	649	CGT	191;190;190	C,A;G;T	181,1;182;180	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5438	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3134	172.9	1	SNP	p	S88P	0	.	.	262	264	TCC	650	652	TCC	191;192;194	T;C;C	181;180;184	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4850	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2685	180.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1556	1558	GGC	259;261;261	G;G;C	248;244;244	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4354	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	187.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1175	1177	GCC	253;254;255	G;C;C	237;238;239	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4354	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	187.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1178	1180	ATG	256;259;261	A;T,G;GAA,GA	242;241,1;249,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4354	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	187.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1190	1192	ACC	248;247;247	A;C;C	236;236;234	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4354	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	187.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1190	1192	ACC	248;247;247	A;C;C	236;236;234	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4354	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	187.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1691	1693	ACC	214;215;215	A;C;C	196;202;203	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4354	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	187.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1745	1747	GCG	228;227;226	G;C;G	208;208;203	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4354	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	187.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1745	1747	GCG	228;227;226	G;C;G	208;208;203	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4354	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	187.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1868	1870	GGT	182;181;183	G;G;T,C	175;173;170,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4354	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	187.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1877	1879	AGC	175;173;171	A,G;G;C	164,1;164;163	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4354	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	187.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1895	1897	CCG	171;175;175	C,G;CG,CGGG,CGG;G	135,10;131,1,1;135	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6212	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3273	189.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1782	1784	CCG	216;218;220	C;C;G	199;203;202	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2302	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1919	119.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	569	569	C	162	C	148	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2834	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1522	184.4	0	.	p	.	0	G48E	NONSYN	142	144	GGA	428	430	GAA	226;227;233	G;A,G;A	213;211,3;218	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2834	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1522	184.4	0	.	p	.	0	G210R	NONSYN	628	630	GGA	914	916	AGA	232;231;233	A;G;A	223;220;220	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2834	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1522	184.4	0	.	p	.	0	S217G	NONSYN	649	651	AGT	935	937	GGT	231;231;230	G;G;T	224;223;221	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2834	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1522	184.4	1	SNP	p	G120K	1	.	.	358	360	AAG	644	646	AAG	230;231;231	A;A;G	216;217;213	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2834	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1522	184.4	1	SNP	p	N121D	0	.	.	361	363	AAC	647	649	AAC	227;226;230	A;A;C	212;214;217	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2834	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1522	184.4	1	SNP	p	A121N	1	.	.	361	363	AAC	647	649	AAC	227;226;230	A;A;C	212;214;217	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10842	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.2	4714	228.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1162	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1055	109.2	1	SNP	p	V57M	1	.	.	169	171	ATG	460	462	ATG	224;225;227	A;T;G	215;217;216	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
